Constriction, Pathologic: Clinical Trials

10 trials for Constriction, Pathologic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 not yet recruiting, 1 recruiting, 1 suspended. 10 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Completed 4, Not yet recruiting 1, Recruiting 1, Suspended 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 24Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1

Follow Constriction, Pathologic: new trials by email Literature Review of Constriction, Pathologic trials Research Report on Constriction, Pathologic

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
FGF-1, Placebo - Peripheral Arterial Disease, Stenosis
Phase 1 / Phase 2Not yet recruitingVenturis Therapeutics, Inc.242028-10-152026-08-19
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
Nestlé NESCAFÉ® TASTER'S CHOICE® House Blend capsule., Placebo - Colorectal Cancer, Coffee
Phase 1 / Phase 2RecruitingMassachusetts General Hospital802024-03-212026-05-05
Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease
Adipose derived allogenic mesenchymal stem cells (adAMSC) - Stenosis; Bowel, Crohn Disease
Phase 1 / Phase 2TerminatedInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz22022-10-242025-03-20
COmbiNing Cutting and Drug-Eluting Balloon for Resistant Arteriovenous Fistula sTenOsis (CONCERTO)
Angioplasty - Arteriovenous Fistula Stenosis
Phase 1CompletedSingapore General Hospital192018-08-152023-07-27
Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)
vonapanitase, Placebo - Peripheral Artery Disease
Phase 1CompletedProteon Therapeutics292016-11-012019-05-02
A Study to Assess the Safety, Tolerability and Potential Efficacy of a Tracheal Replacement Consisting of a Tissue-engineered Tracheal Scaffold With Seeded Mesenchymal Cells
Cadaveric decellularised tracheal scaffold seeded with autologous mesenchymal cells - Tracheomalacia, Tracheal Stenosis
Phase 1SuspendedCell Therapy Catapult42016-09-012018-03-29
T Cell Effector and Regulatory Mechanisms in Asthma
Bronchoscopy, Segmental Allergen Challenge and Broncheoalveolar Lavage, PET-CT imaging(13NN perfusion/ventilation, 18FDG inflammation, and CT imaging) - Asthma, Allergies
Phase 1CompletedAndrew D. Luster, M.D.,Ph.D.1682012-09-012017-09-15
Application of Contrast Enhance Ultrasound to Evaluate Hemodynamics Change in MCA With Moderate to Severe Stenosis
atorvastatin - Stenosis
Phase 1 / Phase 2UnknownCapital Medical University302012-01-012012-06-12
Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy
AlloMEM™ - Colon Cancer, Rectal Cancer
Phase 1CompletedUniversity Hospitals Cleveland Medical Center102010-01-012022-05-12
Safety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal Arteries
vonapanitase - Peripheral Artery Disease
Phase 1WithdrawnProteon Therapeutics2019-05-02

Narrower conditions

Peripheral Arterial Disease (3)  ·  Intermittent Claudication (2)  ·  Arteriovenous Fistula (1)  ·  Asthma (1)  ·  Atherosclerosis (1)  ·  Chronic Limb-Threatening Ischemia (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Crohn Disease (1)  ·  Fatty Liver (1)  ·  Hypersensitivity (1)  ·  Inflammation (1)  ·  Ischemia (1)  ·  Liver Cirrhosis (1)

Broader conditions

Pathological Conditions, Anatomical (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Cardiovascular Diseases (5)  ·  Pathologic Processes (5)  ·  Vascular Diseases (5)  ·  Arterial Occlusive Diseases (4)  ·  Arteriosclerosis (4)  ·  Atherosclerosis (3)  ·  Digestive System Diseases (3)  ·  Gastrointestinal Diseases (3)  ·  Intestinal Diseases (3)  ·  Peripheral Vascular Diseases (3)  ·  Colonic Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)

Interventions

cholesterol-binding protein (2)  ·  Angioplasty (1)  ·  Atorvastatin (1)  ·  Bronchoscopy (1)  ·  Fibroblast Growth Factor 1 (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Ventilation (1)

Sponsors

Proteon Therapeutics (2)  ·  Andrew D. Luster, M.D.,Ph.D. (1)  ·  Capital Medical University (1)  ·  Cell Therapy Catapult (1)  ·  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (1)  ·  Massachusetts General Hospital (1)  ·  Singapore General Hospital (1)  ·  University Hospitals Cleveland Medical Center (1)  ·  Venturis Therapeutics, Inc. (1)

Countries

United States (6)  ·  China (1)  ·  Singapore (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Andrew D Luster, M.D., Ph.D. (1)  ·  Aparna R Parikh, MD, MS (1)  ·  Conor P. Delaney, MD, PhD (1)  ·  Dolores Herreros (1)  ·  Kun Da Zhuang, MBBS (1)  ·  Martin Birchall, MD, PhD (1)  ·  Zhong Qin, master (1)

Results publications

PMID 23670746

NIH funding

R01CA263776 (1), U19AI095261 (1)